151 related articles for article (PubMed ID: 22388692)
1. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
[TBL] [Abstract][Full Text] [Related]
2. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
4. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
Tchu SM; Lynch KL; Wu AH
Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
[TBL] [Abstract][Full Text] [Related]
6. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.
Maximov PY; McDaniel RE; Fernandes DJ; Bhatta P; Korostyshevskiy VR; Curpan RF; Jordan VC
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25258390
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
[TBL] [Abstract][Full Text] [Related]
10. Binding of antitumor tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen to human serum albumin.
Bourassa P; Dubeau S; Maharvi GM; Fauq AH; Thomas TJ; Tajmir-Riahi HA
Biochimie; 2011 Jul; 93(7):1089-101. PubMed ID: 21439346
[TBL] [Abstract][Full Text] [Related]
11. Locating the binding sites of anticancer tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen on bovine serum albumin.
Bourassa P; Dubeau S; Maharvi GM; Fauq AH; Thomas TJ; Tajmir-Riahi HA
Eur J Med Chem; 2011 Sep; 46(9):4344-53. PubMed ID: 21777996
[TBL] [Abstract][Full Text] [Related]
12. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.
Ximenez JPB; de Andrade JM; Marques MP; Coelho EB; Suarez-Kurtz G; Lanchote VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):81. PubMed ID: 31852530
[TBL] [Abstract][Full Text] [Related]
13. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
[TBL] [Abstract][Full Text] [Related]
14. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
[TBL] [Abstract][Full Text] [Related]
16. Locating the binding sites of antitumor drug tamoxifen and its metabolites with DNA.
Bourassa P; Thomas TJ; Tajmir-Riahi HA
J Pharm Biomed Anal; 2014 Jul; 95():193-9. PubMed ID: 24682017
[TBL] [Abstract][Full Text] [Related]
17. An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.
de Vries Schultink AH; Alexi X; van Werkhoven E; Madlensky L; Natarajan L; Flatt SW; Zwart W; Linn SC; Parker BA; Wu AH; Pierce JP; Huitema AD; Beijnen JH
Breast Cancer Res Treat; 2017 Feb; 161(3):567-574. PubMed ID: 28005246
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on the association of tamoxifen, endoxifen, and 4-hydroxytamoxifen with blood lipids in patients with breast cancer.
Siqueira MLS; Andrade SMV; Vieira JLF; Monteiro MC
Biomed Pharmacother; 2021 Oct; 142():111972. PubMed ID: 34391185
[TBL] [Abstract][Full Text] [Related]
19. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
Fan PW; Zhang F; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]